Onyx Bridge Wealth Group LLC Acquires 435 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Onyx Bridge Wealth Group LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 31.0% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 1,836 shares of the healthcare conglomerate’s stock after purchasing an additional 435 shares during the period. Onyx Bridge Wealth Group LLC’s holdings in UnitedHealth Group were worth $967,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Robbins Farley acquired a new stake in UnitedHealth Group during the third quarter worth approximately $25,000. Richelieu Gestion SA acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $26,000. CGC Financial Services LLC raised its position in shares of UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 50 shares in the last quarter. NewSquare Capital LLC raised its position in shares of UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 51 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA raised its position in shares of UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after buying an additional 40 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.6 %

Shares of UnitedHealth Group stock traded up $8.11 during trading on Friday, hitting $501.29. The company’s stock had a trading volume of 6,616,632 shares, compared to its average volume of 4,553,088. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70. The stock has a market cap of $462.16 billion, a price-to-earnings ratio of 30.64, a price-to-earnings-growth ratio of 1.31 and a beta of 0.54. The stock has a 50-day moving average price of $488.63 and a two-hundred day moving average price of $515.13.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.26 earnings per share. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.74 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.50%. UnitedHealth Group’s payout ratio is 45.97%.

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the stock. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research note on Friday. Barclays lifted their price objective on shares of UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research note on Wednesday. Finally, HSBC raised shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective on the stock in a research note on Thursday, April 4th. Four research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.